Care Access - Memphis 2 — Memphis, Tennessee

Care Access - Memphis 2 is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Care Access - Memphis 2 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Chronic Kidney Disease (CKD).

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access - Memphis 2?

Care Access - Memphis 2 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access - Memphis 2 conducted?

Care Access - Memphis 2 has 2 clinical trials on record, with 2 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Chronic Kidney Disease (CKD).

Is Care Access - Memphis 2 accredited by Crixeo Health?

Care Access - Memphis 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access - Memphis 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.